Navigation Links
Sir Walter Bodmer Joins Oxford Genome Sciences Scientific Advisory Board
Date:10/11/2007

OXFORD, England, October 11 /PRNewswire/ -- Oxford Genome Sciences (UK) Ltd "OGeS" announces today that it has further strengthened its Scientific Advisory Board (SAB) with the appointment of Sir Walter Bodmer, currently Head of the Cancer and Immunogenetics Laboratory in the Weatherall Institute of Molecular Medicine at the University of Oxford, which is actively researching the fundamental genetic and biological changes which lead to the development of colorectal cancer.

In addition to the SAB appointment, OGeS and Sir Walter's laboratory will collaborate on the evaluation of OGeS cancer drug development candidates in the area of colorectal cancer.

Prior to taking up his current position, Sir Walter Bodmer was the Director General of the Imperial Cancer Research Fund, London, a position he assumed after having been the Fund's Director of Research for 12 years. Before joining the Imperial Cancer Research Fund, he was the Professor of Genetics at the University of Oxford. Dr Bodmer moved to Oxford University from Stanford University where he was a Professor in the Department of Genetics.

Dr Bodmer, who has developed models for population genetics, worked extensively on the HLA system and the use of somatic cell hybrids for human linkage studies, received his Ph.D. in Genetics in 1959 from the University of Cambridge. He became a fellow of the Royal Society in 1974, a foreign member of the US national Academy of Sciences in 1981 and was knighted in 1986 for his contributions to science.

Dr Christian Rohlff, CEO of OGeS commenting on today's announcement said:

"I am delighted that someone of Walter's scientific standing has agreed to join our Scientific Advisory Board. I am sure his broad ranging experience in genetics and biology and his current work in the field of colorectal cancer will allow him to make an important contribution to OGeS as we continue to further develop our position in the exciting field of personalised medicin
'/>"/>

SOURCE Oxford Genome Sciences
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Chemical-petroleum executive joins Virent Energy board
2. Schneider National exec joins TrafficCast board
3. Doyle joins governors in support of stem cell bill
4. Genomics researcher Hood joins NimbleGen board
5. Fergus joins Baird Venture Partners, Caden Bio
6. Meier joins Broadlook Technologies as COO
7. Prodesse joins forces with Invitrogen
8. Wisconsin joins price-fixing suit vs. D-RAM makers
9. Napier joins board of Third Wave Technologies
10. Schmidt rejoins Renaissance Learning
11. Tommy Thompson joins drug company as advisor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/3/2008)...Symbol: MS, EDMONTON, Oct. 3 /PRNewswire-FirstCal...loper in the treatment of multiple sclerosis (MS),...Monitoring Board (DSMB) for the,Company,s U.S. piv...8298),in patients with secondary progressive MS ha... the trial continue as per the protocol., This wa...
(Date:10/3/2008)...or Ap3ana, CTI,s ,personalized medicine, venture, ...erapeutics, Inc. (CTI),(Nasdaq: CTIC ) announced ...t recently President and COO of a Tyr Pharma and f...mics Institute of the Novartis Research,Foundation... Bresso, Italy,CTI Europe currently conducts the ...
(Date:10/2/2008)...2 /- Helix BioPharma,Corp. ... its private,placement announced on September 30, ...ss proceeds totaling CDN$11,424,000., Each unit c...mmon share,purchase warrant, with each whole commo...urchase, subject to adjustment, one common share a...
(Date:10/2/2008)...Provides Business Update to Investors, WILMINGTON...today at an,investor conference, DuPont Vice Presi...ny,s plans to bring its two advanced biofuels prog... technical progress toward the,commercialization o...stocks,economically into biofuels., "Biobutanol a...
Breaking Biology Technology:BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board 2Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 2Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 3Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 4Helix Biopharma Closes $11.4 Million Private Placement 2DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels 2DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels 3
...ggests Wisconsin is slowly making progress when it...judged by indicators such as producing patents, in...reating high-tech jobs. The natural question: Why ...ut a variety of factors promise more progress pro...ion. , ,The report, commissioned by the Wisconsin...
...olumn over the last few years knows about my prope...e information into tidy boxes in some meaningful o...out of the information for myself). While my list ...ow enlightened me about how lists could be used to...n one of my companies, I even adapted the Letterma...
...y to pick up a pizza the other night. I ran into ...rbis, the massive digital image library. Doug is...g product for digital pictures. , ,If, like me, yo...red on your mobile phone the moment for sharing ha...package provides everything you need to create a t...
...chnology-wise has already been invented. I,ve been...last 15 years about technology innovation, and the... all that innovation. From a quick look into the i...ular soapbox is getting crowded. Pick up any indus...ons about process, best practices, business alignm...
Other Biology Technology:Heres why Wisconsins tech economy indicators are up 2Heres why Wisconsins tech economy indicators are up 3Though Weakening, Biotech IPO Market Still Viable, Burril & Co. Says 2Though Weakening, Biotech IPO Market Still Viable, Burril & Co. Says 3Though Weakening, Biotech IPO Market Still Viable, Burril & Co. Says 4ZoomAlbum operates virtually 2ZoomAlbum operates virtually 3The end of technology history 2The end of technology history 3
(Date:10/6/2008)...722; The American Physiological Society has establ...estricted grants of up to $2,000 to support physio...o suffered losses as a result of Hurricane Ike. Th...nd also affected other areas of the country. , T... are either APS members or working in the laborato...
(Date:10/5/2008)...rnal of Cell Biology how the altered behavior of ...cells., On 2D surfaces, cells may migrate randoml... link the cell to the extracellular matrix, are kn...y how has been unclear. Recent work has suggested ...t, while an integrin called avb3 has been associat...
(Date:10/5/2008)...sts report online this week in Nature that they ...ells to a gene associated with Crohn,s disease, an...lammatory bowel disorder. , The link to immune c...y School of Medicine in St. Louis because they and...rected immune responses in the intestine that dama...
(Date:10/3/2008)...008)Researchers from Harvard Medical School and th...how beetles and bacteria form a symbiotic and mutu... the destruction of pine forests. In addition, the...this whole phenomenon. , The context of this di... includes some of the most unlikely characters and...
Breaking Biology News(10 mins):Form of Crohn's disease traced to disabled gut cells 2Cross kingdom conflicts on a beetle's back 2Cross kingdom conflicts on a beetle's back 3Peripheral Arterial Disease to be Treated With New Medicated Stent in Trial at Montefiore 517 1Peripheral Arterial Disease to be Treated With New Medicated Stent in Trial at Montefiore 517 2Cryo Cell International Inc Reports Third Quarter 2007 Results 3697 1Cryo Cell International Inc Reports Third Quarter 2007 Results 3697 2Cryo Cell International Inc Reports Third Quarter 2007 Results 3697 3Cryo Cell International Inc Reports Third Quarter 2007 Results 3697 4Cryo Cell International Inc Reports Third Quarter 2007 Results 3697 5Nyer Medical Group Inc Reports EPS of 24 02 on Record Revenues of 2469 9 Million for Fiscal Year Ended 2007 3692 1Nyer Medical Group Inc Reports EPS of 24 02 on Record Revenues of 2469 9 Million for Fiscal Year Ended 2007 3692 2Nyer Medical Group Inc Reports EPS of 24 02 on Record Revenues of 2469 9 Million for Fiscal Year Ended 2007 3692 3Nyer Medical Group Inc Reports EPS of 24 02 on Record Revenues of 2469 9 Million for Fiscal Year Ended 2007 3692 4Americas Top Hospitals Are Real Lifesavers 3690 1Americas Top Hospitals Are Real Lifesavers 3690 2
...have discovered a vast network of neurons in the b...s the effects of reproductive status on other brai...ound neural circuits that coordinate a complex int...nd brain areas that carry the neural signals trigg...heromones, chemical signals produced by animals. T...
...ntified two new genes that operate as regulators i...ococcus aureus , one of the bacteria most frequent...ts, and has explained the functioning of a structu... was the subject of a PhD thesis recently defended...IC and Public University of Navarra centre, and is...
...ngi, such as white rot, are particularly harmful f... Soil samples are investigated to detect this; a l...with the Laboratory for Nematology (University of ...ular technique to detect the stem nematode and whi... Blgg will start using the new system in November ...
...herapy (HAART) for HIV infection remain susceptibl...or HIV-infected patients not on HAART, according t...ctious Diseases, now available online. , Opportun...fatal for immunocompromised patients. HAART not on...n helps to keep other infections such as TB under ...
Other Biology News:The brain is broadly wired for reproduction 2The brain is broadly wired for reproduction 3The brain is broadly wired for reproduction 4The brain is broadly wired for reproduction 5Genes involved in biofilms 2DNA technique measures suitability of soil for onion crops 2Tuberculosis still a risk for patients receiving HIV drugs 2